Helicobacter pylori: a historical perspective 1983-2003.
Fraser
Alan
A
Department of Medicine, University of Auckland, Auckland, New Zealand. a.fraser@auckland.ac.nz
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D015897:Comorbidity; D004359:Drug Therapy, Combination; D004942:Esophagitis, Peptic / Q000453:epidemiology / Q000382:microbiology; D016481:Helicobacter Infections / Q000188:drug therapy / Q000266:history* / Q000382:microbiology; D016480:Helicobacter pylori / Q000302:isolation & purification*; D049673:History, 20th Century; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use; D009942:Organometallic Compounds / Q000627:therapeutic use; D010437:Peptic Ulcer / Q000139:chemically induced / Q000453:epidemiology / Q000382:microbiology; D015995:Prevalence; D013274:Stomach Neoplasms / Q000453:epidemiology / Q000382:microbiology; D013752:Tetracycline / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D009942:Organometallic Compounds; D008795:Metronidazole; D013752:Tetracycline; C002791:bismuth tripotassium dicitrate